Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Dactolisib Potential treatment - pre-clinical evidence Experimental Antiviral Mar/17/2021 2 0
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/15/2021 4 0
Bortezomib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 3 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/08/2021 40 43
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/01/2021 26 15
Genz-667161 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021 1 0
Genz-123346 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021 1 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Feb/12/2021 26 14